Are Adverse Events in COVID-19 Vaccine Trials Under-Reported?
![Are Adverse Events in COVID-19 Vaccine Trials Under-Reported? Are Adverse Events in COVID-19 Vaccine Trials Under-Reported?](https://thevaccinereaction.org/wp-content/uploads/2022/01/side-effects-1024x683.jpg)
Phase III controlled trials are considered the ‘gold standard’ for assessing vaccine efficacy and safety in humans. These are the trials upon which authorities have assured the public that COVID-19 vaccines are “safe and effective.” The benefits of the vaccines in reducing disease severity and hospitalizations are well-known, but what do we know about the adverse events?Data on adverse events is vital for effective decision-making by regulators, policy makers, doctors, and patients.
COVID-19 Vaccine Trial Volunteer in India Develops Encephalopathy and Sues
![COVID-19 Vaccine Trial Volunteer in India Develops Encephalopathy and Sues COVID-19 Vaccine Trial Volunteer in India Develops Encephalopathy and Sues](https://thevaccinereaction.org/wp-content/uploads/2020/12/suffering-from-headache-1024x682.jpg)
A 40-year old business consultant in India, who volunteered to be a participant in clinical trials of the experimental COVID-19 vaccine (Covishield) created by AstraZeneca and Oxford University is suing Serum Institute of India (SII), which is producing the vaccine in India, for 50 million rupees ($680,000) after he developed acute encephalopathy (brain dysfunction) within […]
AstraZeneca Halts, Resumes COVID-19 Vaccine Trial After Serious Neurological Event
![AstraZeneca Halts, Resumes COVID-19 Vaccine Trial After Serious Neurological Event AstraZeneca Halts, Resumes COVID-19 Vaccine Trial After Serious Neurological Event](https://thevaccinereaction.org/wp-content/uploads/2020/09/coronavirus-vaccine-testing-1024x682.jpg)
News update, Sept. 15, 2020—U.S. regulators paused AstraZeneca’s vaccine trial in the U.S. while the National Institutes of Health (NIH) launches an investigation of its own into a serious side effect in an unnamed patient in Britain. “The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader […]